Results 11 to 20 of about 17,357,527 (148)

Role for polo-like kinase 4 in mediation of cytokinesis. [PDF]

open access: yesProc Natl Acad Sci U S A, 2019
The mitotic protein polo-like kinase 4 (PLK4) plays a critical role in centrosome duplication for cell division. By using immunofluorescence, we confirm that PLK4 is localized to centrosomes.
Press MF   +10 more
europepmc   +4 more sources

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer [PDF]

open access: yesBreast, 2021
Development of novel multimodality radiotherapy treatments in metastatic breast cancer, especially in the most aggressive triple negative (TNBC) subtype, is of significant clinical interest. Here we show that a novel inhibitor of Polo-Like Kinase 4 (PLK4)
Armen Parsyan   +6 more
doaj   +2 more sources

Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB) [PDF]

open access: yesBioengineering, 2018
Neuroblastoma (NB) is the most common extracranial solid tumor in pediatrics, with rare occurrences of primary and metastatic tumors in the central nervous system (CNS).
Anders W. Bailey   +7 more
doaj   +2 more sources

Chemical Probe for Imaging of Polo-like Kinase 4 and Centrioles [PDF]

open access: yesJACS Au, 2023
Aleksandar Salim   +6 more
doaj   +2 more sources

High expression of polo-like kinase 4 predicts worse progression-free survival in diffuse large B cell lymphoma patients treated with R-CHOP [PDF]

open access: yesWorld Journal of Surgical Oncology
Background Polo-like kinase 4 (PLK4) has been shown to be a tumor-promoting factor with multiple impacts on cancer growth, invasiveness, and treatment sensitivity.
Dehong Xu   +4 more
doaj   +2 more sources

Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection [PDF]

open access: yesBMC Women's Health
Background Polo-like kinase 4 (PLK4) serves as a marker for tumor features and poor outcomes in cancers. This study aimed to explore the associations of tumor PLK4 protein expression with tumor characteristics and survival in endometrial cancer (EC ...
Qinyan Zhao, Minli Wang, Mingcong Chen
doaj   +2 more sources

Polo-like kinase 4: the odd one out of the family [PDF]

open access: yesCell Division, 2010
Polo-like kinase 4 (PLK4) is a unique member of the Polo-like family of kinases that shares little homology with its siblings and has an essential role in centriole duplication.
Bornens Michel, Sillibourne James E
doaj   +2 more sources

Polo like kinase 2 tumour suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer [PDF]

open access: yes, 2012
The polo-like kinase PLK2 has recently been identified as a potential theranostic marker in the management of chemotherapy sensitive cancers. The methylation status of the PLK2 CpG island varies with sensitivity to paclitaxel and platinum in ovarian ...
Mcneish, I.   +6 more
core   +8 more sources

P471: POLO-LIKE KINASE 4 INHIBITION INDUCED ANTI-LEUKAEMIC EFFECTS THROUGH HISTONE MODIFICATION IN TP53 MUTATED ACUTE MYELOID LEUKAEMIA [PDF]

open access: yesHemaSphere, 2023
Wing Lam   +16 more
doaj   +2 more sources

Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4. [PDF]

open access: yesMol Cancer Res, 2022
Centrosome amplification (CA) has been implicated in the progression of various cancer types. Although studies have shown that overexpression of PLK4 promotes CA, the effect of tumor microenvironment on polo-like kinase 4 (PLK4) regulation is ...
Mittal K   +17 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy